What Does FDA Orphan Drug Designation Mean for Cure Rare Disease's SCA3 Treatment

OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA